Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $280
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $310
Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)
Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $350
Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $370
Jefferies Remains a Buy on Amgen (AMGN)
BMO Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $362
Wells Fargo & Co has lowered Amgen's Target Price to 280 dollars.
Bernstein Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Amgen Is Maintained at Equal-Weight by Wells Fargo
Amgen Analyst Ratings
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Cuts Target Price to $280
Goldman Sachs lowered Amgen's Target Price to $370.
Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $370
Goldman Sachs Adjusts Price Target on Amgen to $370 From $375, Maintains Buy Rating
Truist Financial Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $298
Amgen Analyst Ratings
Truist Financial Maintains Amgen(AMGN.US) With Hold Rating, Announces Target Price $298
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $324